Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population. In so-called wet AMD, new, abnormal blood vessels grow in the central part of ...

Age-related macular degeneration or AMD, is an eye disease that damages the retina and can lead to vision loss. Wet AMD is a more serious form where abnormal blood vessel growth causes sudden ...

Also Read: Analyst Sees Wendy’s Playing Catch-Up, Needs Stronger Focus on Tech, Talent & Global Expansion Ocular Therapeutix has completed randomization in the first wet AMD trial, SOL-1.

This announcement comes ahead of further presentations on the CLS-AX wet AMD program scheduled at the Macula Society 48th Annual Meeting and the 5th Annual Wet AMD & Diabetic Eye Disease Drug Summit.

Wet AMD remains the leading cause of vision loss in the elderly, impacting about 3.5 million people in the US and Europe alone. The unmet medical need in wet AMD is significant, with many patients ...

Medical treatments may also help. Wet age-related macular degeneration (wet AMD) is an eye condition that leads to blind spots in your central vision. Unlike the more common “dry” form of AMD ...

“4D-150 has the clear potential to address the greatest unmet needs for the millions of patients with wet AMD and DME: multi-year relief from frequent and burdensome injections into the eye and ...

Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population. In so-called wet AMD, new, abnormal blood vessels grow in the central part of ...

(RTTNews) - Outlook Therapeutics, Inc. (OTLK), Friday said it has resubmitted its Biologics License Application (BLA) to the U.S.Food and Drug Administration or FDA for ONS-5010 to treat wet age ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...